Myeloid-derived suppressor cell development is regulated by a STAT/IRF-8 axis

JD Waight, C Netherby, ML Hensen… - The Journal of …, 2013 - Am Soc Clin Investig
Myeloid-derived suppressor cells (MDSCs) comprise immature myeloid populations
produced in diverse pathologies, including neoplasia. Because MDSCs can impair …

A pilot study of circulating miRNAs as potential biomarkers of early stage breast cancer

H Zhao, J Shen, L Medico, D Wang, CB Ambrosone… - PloS one, 2010 - journals.plos.org
Background To date, there are no highly sensitive and specific minimally invasive
biomarkers for detection of breast cancer at an early stage. The occurrence of circulating …

Unlocking biomarker discovery: large scale application of aptamer proteomic technology for early detection of lung cancer

RM Ostroff, WL Bigbee, W Franklin, L Gold, M Mehan… - PloS one, 2010 - journals.plos.org
Background Lung cancer is the leading cause of cancer deaths worldwide. New diagnostics
are needed to detect early stage lung cancer because it may be cured with surgery …

Association between global DNA hypomethylation in leukocytes and risk of breast cancer

JY Choi, SR James, PA Link, SE McCann… - …, 2009 - academic.oup.com
Background: Global DNA hypomethylation may result in chromosomal instability and
oncogene activation, and as a surrogate of systemic methylation activity, may be associated …

Mitochondrial copy number and risk of breast cancer: a pilot study

J Shen, M Platek, A Mahasneh, CB Ambrosone… - Mitochondrion, 2010 - Elsevier
It has been proposed that the copy number of mitochondria DNA (mtDNA) per cell reflects
gene–environment interactions between unknown hereditary factors and exposures …

Common breast cancer susceptibility loci are associated with triple-negative breast cancer

KN Stevens, CM Vachon, AM Lee, S Slager, T Lesnick… - Cancer research, 2011 - AACR
Triple-negative breast cancers are an aggressive subtype of breast cancer with poor
survival, but there remains little known about the etiologic factors that promote its initiation …

Pretreatment serum concentrations of 25-hydroxyvitamin D and breast cancer prognostic characteristics: a case-control and a case-series study

S Yao, LE Sucheston, AE Millen, CS Johnson… - PloS one, 2011 - journals.plos.org
Background Results from epidemiologic studies on the relationship between vitamin D and
breast cancer risk are inconclusive. It is possible that vitamin D may be effective in reducing …

NY-ESO-1 cancer testis antigen demonstrates high immunogenicity in triple negative breast cancer

FO Ademuyiwa, W Bshara, K Attwood, C Morrison… - PloS one, 2012 - journals.plos.org
Purpose NY-ESO-1 cancer testis (CT) antigen is an attractive candidate for immunotherapy
as a result of its high immunogenicity. The aim of this study was to explore the potential for …

[HTML][HTML] Circulating miR-148b and miR-133a as biomarkers for breast cancer detection

J Shen, Q Hu, M Schrauder, L Yan, D Wang, L Medico… - Oncotarget, 2014 - ncbi.nlm.nih.gov
Circulating microRNAs have drawn a great deal of attention as promising novel biomarkers
for breast cancer. However, to date, the results are mixed. Here, we performed a three-stage …

Quantitative global lipidomics analysis of patients with ovarian cancer versus benign adnexal mass

MF Buas, CW Drescher, N Urban, CI Li, L Bettcher… - Scientific reports, 2021 - nature.com
Altered lipid metabolism has emerged as an important feature of ovarian cancer (OC), yet
the translational potential of lipid metabolites to aid in diagnosis and triage remains …